Try our Advanced Search for more refined results

June 03, 2014

ASTRAZENECA PHARMACEUTICALS LP et al v. SAGENT PHARMACEUTICALS, INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 13, 2016

    AstraZeneca OKs Sandoz Cancer-Drug Generic For 2019

    Sandoz Inc. will be able to release a generic version of AstraZeneca's breast cancer drug Faslodex at the end of March 2019, according to a patent infringement settlement approved by a New Jersey federal judge on Tuesday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login